National Health Investors, Inc. (NYSE:NHI) Given Consensus Rating of “Moderate Buy” by Analysts

by · The Markets Daily

Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $83.5714.

A number of equities analysts recently issued reports on NHI shares. Deutsche Bank Aktiengesellschaft dropped their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Wells Fargo & Company reduced their target price on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Tuesday, September 1st. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Truist Financial lowered their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, September 2nd. Finally, BMO Capital Markets dropped their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th.

Get Our Latest Analysis on NHI

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

Several institutional investors have recently bought and sold shares of the company. International Assets Investment Management LLC purchased a new position in National Health Investors in the fourth quarter worth $27,000. EverSource Wealth Advisors LLC lifted its holdings in shares of National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors during the 4th quarter valued at $33,000. Allworth Financial LP purchased a new position in National Health Investors during the 2nd quarter worth $42,000. Finally, Advisory Services Network LLC purchased a new position in National Health Investors during the 3rd quarter worth $65,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Stock Performance

Shares of NYSE:NHI opened at $70.90 on Tuesday. The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of 20.49, a PEG ratio of 3.78 and a beta of 0.52. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The firm’s 50-day moving average is $75.25 and its 200 day moving average is $77.98. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts predict that National Health Investors will post 4.76 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.2%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s payout ratio is 106.36%.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Read More